FEMY vs ICU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

FEMY

45.2
AI Score
VS
FEMY Wins

ICU

31.7
AI Score

Investment Advisor Scores

FEMY

45score
Recommendation
HOLD

ICU

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric FEMY ICU Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -18.9% 82.0% ICU
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.2/100 31.7/100 FEMY
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

FEMY 1M: -33.9% · 3M: -49.8% ICU 1M: +62.8% · 3M: -1.5%

Current Technical Phase

FEMY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.3%), weak momentum, RSI 32

RSI (14): 32.0 · Price: $2.05

ICU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 77.5 · Price: $4.69

Fundamentals Snapshot

Metric FEMY ICU
Market Cap — —
Forward P/E -1.0 -2.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.8%
Gross Margin 0.6% 0.9%
Operating Margin -15.3% -6.2%
EPS -2.72 -1.89
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, FEMY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.